Sunshine Biopharma Inc. Warrant
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor … Read more
Market Cap & Net Worth: Sunshine Biopharma Inc. Warrant (SBFMW)
Sunshine Biopharma Inc. Warrant (NASDAQ:SBFMW) has a market capitalization of $814.24 ($814.24) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #37841 globally and #12330 in its home market, demonstrating a -14.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sunshine Biopharma Inc. Warrant's stock price $0.09 by its total outstanding shares 9568 (9.57K).
Sunshine Biopharma Inc. Warrant Market Cap History: 2022 to 2026
Sunshine Biopharma Inc. Warrant's market capitalization history from 2022 to 2026. Data shows change from $3.13K to $814.24 (-38.01% CAGR).
Sunshine Biopharma Inc. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sunshine Biopharma Inc. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Sunshine Biopharma Inc. Warrant's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $3.13K | $4.35 Million | -$26.74 Million | 0.00x | N/A |
| 2023 | $1.91K | $24.09 Million | -$4.51 Million | 0.00x | N/A |
| 2024 | $1.54K | $34.87 Million | -$5.13 Million | 0.00x | N/A |
Competitor Companies of SBFMW by Market Capitalization
Companies near Sunshine Biopharma Inc. Warrant in the global market cap rankings as of March 19, 2026.
Key companies related to Sunshine Biopharma Inc. Warrant by market ranking:
- IN8BIO INC. DL-0001 (F:6JH): Ranked #37832 globally with a market cap of $419.46K USD ( €408.64K EUR).
- Singapore Reinsurance Corporation Limited (STU:S49): Ranked #37833 globally with a market cap of $419.03K USD ( €408.23K EUR).
- VIASAT - Dusseldorf Stock Exchang (DU:VS1): Ranked #37842 globally with a market cap of $416.61K USD ( €405.86K EUR).
- ELCORA ADVANCED MAT.CORP. (F:ELM): Ranked #37843 globally with a market cap of $416.50K USD ( €405.76K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #37832 | IN8BIO INC. DL-0001 | F:6JH | $419.46K | €2.41 |
| #37833 | Singapore Reinsurance Corporation Limited | STU:S49 | $419.03K | €43.60 |
| #37842 | VIASAT - Dusseldorf Stock Exchang | DU:VS1 | $416.61K | €40.86 |
| #37843 | ELCORA ADVANCED MAT.CORP. | F:ELM | $416.50K | €0.07 |
Sunshine Biopharma Inc. Warrant Historical Marketcap From 2022 to 2026
Between 2022 and today, Sunshine Biopharma Inc. Warrant's market cap moved from $3.13K to $ 814.24, with a yearly change of -38.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $814.24 | -55.21% |
| 2025 | $1.82K | +18.09% |
| 2024 | $1.54K | -19.55% |
| 2023 | $1.91K | -38.88% |
| 2022 | $3.13K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sunshine Biopharma Inc. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $814.24 USD |
| MoneyControl | $814.24 USD |
| MarketWatch | $814.24 USD |
| marketcap.company | $814.24 USD |
| Reuters | $814.24 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.